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To ﬁnd out whether food-producing animals (FPAs) are a source of extraintestinal expanded-spectrum cepha-
losporin-resistant Escherichia coli (ESCR-EC) infections in humans, Medline, Embase, and the Cochrane Da-
tabase of Systematic Reviews were systematically reviewed. Thirty-four original, peer-reviewed publications were
identiﬁed for inclusion. Six molecular epidemiology studies supported the transfer of resistance via whole bac-
terium transmission (WBT), which was best characterized among poultry in the Netherlands. Thirteen molec-
ular epidemiology studies supported transmission of resistance via mobile genetic elements, which
demonstrated greater diversity of geography and host FPA. Seventeen molecular epidemiology studies did
not support WBT and two did not support mobile genetic element–mediated transmission. Four observational
epidemiology studies were consistent with zoonotic transmission. Overall, there is evidence that a proportion of
human extraintestinal ESCR-EC infections originate from FPAs. Poultry, in particular, is probably a source, but
the quantitative and geographical extent of the problem is unclear and requires further investigation.
Keywords. zoonosis; ESBL; E. coli; ST131; urinary tract; poultry.
The global spread, rapidly rising incidence, and increased
mortality of expanded-spectrum cephalosporin-resistant
Escherichia coli (ESCR-EC) infections over the past dec-
ade have made it one of the biggest threats to human
health worldwide [1, 2]. In many regions, this rising in-
cidence has coincided with a shift in the epidemiology of
human infection, from healthcare associated to commu-
nity acquired [1]. Discovering the origins of this shift
may reveal new targets for public health intervention [3].
From as early as 1969, it has been speculated that
food-producing animals (FPAs) may be a potential
source of antimicrobial-resistant E. coli in humans
[4, 5]. The use of large volumes of penicillins and
cephalosporins in FPAs has been proposed as a con-
tributing factor to the current ESCR-EC pandemic
in humans [6]. Numerous studies have suggested that
the use of antibiotics in FPAs directly correlates to
the emergence of ESCR-EC within animal populations
[7–11]. However, whether ESCR-EC from animals
represents a source for human infections has been
controversial [12–14].
It has been hypothesized that widespread transmis-
sion of resistant bacteria between FPAs and humans
may occur via the ingestion of contaminated meat
[15]. ESCR Enterobacteriaceae, residing in the gut of
FPAs, may directly contaminate meat products during
slaughter, or may be released into the environment
and indirectly contaminate produce via an intermediary
mechanism, such as soil or water. Following ingestion,
resistant strains may colonize the intestinal tract and
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subsequently proceed to cause infections at extraintestinal sites,
such as the urinary tract [16, 17].
Within this transmission paradigm, human ESCR-EC infec-
tions may occur via two mechanisms. First, the entire resistance
harboring bacterium may be directly transmitted from animal
to human. In this mechanism of whole bacterium transmission
(WBT), a bacterial clone from the FPA propagates through the
food production process, is ingested, and goes on to cause
human extraintestinal infection with minimal genetic changes.
Alternatively, the genes mediating ESCR may be transferred
from Enterobacteriaceae of animal origin to a human patho-
genic E. coli, via plasmids or other mobile genetic elements
(MGEs). This may occur at any stage of the transmission para-
digm, including within the human gastrointestinal tract. We
termed this process MGE-mediated transmission.
In the event that FPAs are a signiﬁcant source of human
ESCR-EC infections, strategies incorporating the veterinary, ag-
ricultural, and retail industries may be effective at reducing the
escalating global burden of ESCR-EC [18]. To address this
knowledge gap, we performed a systematic review of all avail-
able published evidence that supported, or did not support,
the hypothesis that FPAs are a source of extraintestinal ESCR-
EC infection in humans.
METHODS
Protocol
A systematic review of published literature was undertaken, fol-
lowing the Preferred Reporting Items for Systemic Reviews and
Meta-analyses guidelines [19]. Our initial aim was to undertake
a systematic review and meta-analysis to quantify the contribu-
tion of FPA to human ESCR-EC infections, however, evaluation
of the published studies indicated that only 1 study was suitable
for meta-analysis.
Data Sources and Search Strategy
We developed search strategies for 3 electronic databases: Med-
line, Embase, and the Cochrane Database of Systematic Re-
views. The most recent search was conducted in October
2013. Language of publications reviewed was not restricted.
Terms included Escherichia coli, technical (eg, bovine) and non-
technical (eg, cow) animal descriptors, food descriptors (eg,
beef ), and antimicrobial resistance terminology (eg, cephalo-
sporin resistance, extended-spectrum β-lactamase [ESBL]).
Full details are included in the Supplementary Data. The bibli-
ographies of all included publications and relevant review arti-
cles on this topic were searched for further publications.
Study Selection
Original research studies that presented a comparative analysis
addressing the research question were included. We applied no
exclusion criteria or limitations based on the methodology used
for this comparison. Studies that reported only on animal or
human data, and did not address the research question of the
relationship between these 2 groups, were excluded, as were
those that analyzed only enteropathogenic E. coli. Studies that
reported only on transmission of resistance after physical con-
tact between FPAs and humans (eg, farm or abattoir workers)
were excluded, due to the limited generalizability of this
phenomenon.
Data Extraction
Two authors (B. L., B. A. R.) independently reviewed all ab-
stracts identiﬁed by the search strategy. The full text of all pub-
lications potentially meeting inclusion criteria, selected by
either researcher, was obtained for review. After full indepen-
dent review, any disagreement about the relevance of an article
to the research question was settled by a discussion. Data were
extracted from the publications by 1 author (B. L.).
RESULTS
In total, 2301 abstracts were reviewed and 34 full articles were
identiﬁed with relevant data (Figure 1). The annual frequency of
publications has increased markedly over the last decade (see
Supplementary Data).
Molecular Evidence Supporting Transmission Between Animals
and Humans
Whole Bacterium Transmission
Six published articles provide data to support the hypothesis of
WBT of ESCR-EC between poultry and extraintestinal human
sites (Table 1). Publications originate from 3 regions: the Neth-
erlands, Spain, and North America.
Three Dutch studies illustrating WBT of ESCR-EC between
poultry and extraintestinal human infections were identiﬁed
[15, 20, 21]. All 3 collected geographically and temporally
matched isolates between 2006 and 2010, found a similar distri-
bution of ESBL genes, and, using multilocus sequence typing
(MLST), found that animal- and human-sourced bacteria clus-
tered in identical clonal complexes. An extended chromosomal
analysis, involving pulsed-ﬁeld gel electrophoresis (PFGE) and
multivariate discriminant function analysis, of the retail chicken,
human rectal, and blood culture isolates found extensive similar-
ity between E. coli from these sources [15, 20, 21]. Collectively,
clonally related isolates were identiﬁed at all levels of the trans-
mission paradigm, including poultry ﬂocks, retail chicken meat,
and human commensal and extraintestinal clinical sources.
The ﬁndings in all 3 studies were limited to poultry despite
substantial sampling of non-poultry retail meats [21]. Signiﬁ-
cantly fewer ESCR-EC isolates were identiﬁed in non–poultry
meat types [21].
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Two Spanish studies provide limited evidence, both based on
PFGE, to suggest that some WBT of ESCR-EC between poultry
and humans may occur in this country [22, 23] (Table 1). One
study was conducted retrospectively sampling E. coli sequence
type 131 (ST131) isolates selected from much larger previous
samplings over a 17-year period [23].
One supportive study from North America identiﬁed genetic
relatedness of isolates from FPAs and humans, albeit using mo-
lecular techniques that have a limited resolution [24] (Table 1).
No distinction was made between freshly slaughtered chicken
carcass samples and retail poultry products in this study.
Mobile Genetic Element-Mediated Transmission
Thirteen studies provide data to support the hypothesis of
MGE-mediated transmission of ESCR between animal bacteria
and E. coli causing human extraintestinal infections (Table 2).
The geographical setting, host animals, and host bacteria that
appear to mediate MGE-mediated transmission are diverse.
Studies originated from Western Europe (n = 6), North Amer-
ica (n = 3), and Asia (n = 2). Two additional studies were con-
ducted across multiple continents. The animal hosts included
poultry, pigs, and cattle. Whereas all MGEs were identiﬁed
among E. coli in humans, the host Enterobacteriaceae for the
MGE in animals included Salmonella species, Klebsiella pneu-
moniae, and E. coli.
The genes encoding ESCR that are described appear to vary
by geographical location. ESBL genes, especially the blaCTX-M
family, predominated in Europe, whereas blaCMY-2 was pre-
dominant in North America, and both were prevalent in Asia.
Molecular Studies Not Demonstrating Transmission Between
Animals and Humans
Whole Bacterium Transmission
Seventeen studies did not demonstrate direct WBT of ESCR-EC
in North America, Europe, and Asia. These comprised 8 studies
that found evidence to support MGE-mediated transmission
and have already been discussed (Table 2) [25–32], and 9 fur-
ther studies (Table 3).
Of the 9 studies, 3 suggest that FPAs do not appear to play the
predominant role in the spread of a single clone, E. coli ST131,
among humans [33–35]. Two studies did not isolate any ST131
from FPAs [33, 35]. One extensive study found that PFGE-
deﬁned pulsotypes of ST131 were predominantly source specif-
ic, although some pulsotypes contained isolates from both
human and FPA sources [34].
The remaining 6 studies compared a variety of isolates from
animal and human sources, and did not ﬁnd any signiﬁcant ev-
idence of transmission [14, 36–40]. One of these studies con-
tained isolates from 3 European countries, including the
Netherlands [40].
MGE-Mediated Transmission
Two studies did not demonstrate MGE-mediated transmission
of ESCR genes between E. coli from FPAs and human sources
Figure 1. Flow diagram detailing study selection. Abbreviations: ESCR, expanded-spectrum cephalosporin-resistant; FPA, food-producing animal.
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Table 1. Molecular Evidence Supporting Whole Bacterium Transmission
Location,
Sampling Dates
Nature of
Sample
Selection
Source and No. of ESCR Escherichia coli Isolates Whole Bacterium Comparison
Animal
Meata (ESCR-EC/
Meat Samples) Human
Methods of Comparison, No. of
Human ESCR-EC Compared
Using This Method Results
The Netherlands,
2006–2010 [15]
Any ESCR-EC Healthy
poultry,
n = 35
Retail chicken,
n = 81/98
Urine and blood,
n = 409
ESBL genotype frequency,
n = 208
51 human isolates carried blaCTX-M-1 and 14 carried blaTEM-52.
These were the 2 most common ESBL genes identified in
poultry
MLST plus plasmid typing, n = 27 8 human isolates had the same sequence type as poultry isolates
(ST10, ST58 or ST117) and carried the ESBL on the same
plasmid type (IncI1 CC7, 3, or 5)
The Netherlands,
2008–2009
[20, 21]
Any ESCR-EC . . . Retail chicken,
n = 68/89
Other meats, n = 8/
173
Rectal swabs
(commensal), n = 45
Blood culture, n = 23
ESBL genotype frequency, n = 55 22 human rectal swab and 5 bloodstream ESCR E. coli contained
blaCTX-M-1 genes, the most common ESBL genes in FPA
MLST, n = 60 25 human rectal and 9 bloodstream isolates shared the same ST
group as FPA. Clonal complexes ST10, ST155, and ST117 were
the most frequent groups.
Statistical analysisb, n = 58 23 human isolates classified as chicken meat isolates at highest
level of discriminatory power (Wilks λ = 0.08)
AFLP and PFGE, n = 14 1 human rectal isolate (B1 group) perfectly matched 1 chicken
meat isolate on AFLP and PFGE. 3 human isolates (2 blood and
1 rectal) were similar to chicken meat isolates based on AFLP,
but were less related on PFGE
Spain, 1993–2010
[23]
Highly
selectedc
Poultry,
n = 3d
Retail chicken,
n = 4/100
Extraintestinal, n = 5e PFGE, all human and FPA isolates
included
3 human blaCTX-M-9 isolates (2007–2010) showed >90.9%
similarity to 4 ESCR retail chicken isolates and 2 poultry ESCR
isolates.
Spain, 2003 [22] Any ESCR-EC Poultry,
n = 57
Pigs, n = 29
. . . Extraintestinal, n = 80 Serotyping 55 human isolates shared serotypes identified in poultry and pig
isolates, namely O2:HNM (24 isolates), O2:H6 (14 isolates),
and O25 (17 isolates)
Phylogenetic group, MLST,
virulence genes and PFGE,
n = 6 (O2), n = 17 (O25)
2 human O2:HNM isolates matched 3 pig isolates in terms of
phylogroup (A) and MLST (ST10), but not virulence profile or
PFGE
1 human O25a blaCTX-M-32 isolate matched 1 chicken isolate in
terms of phylogroup (D), MLST (ST648), virulence profile, and
PFGE (96.6% match)
USA, 2002–2004
[24]
Any ESCR-EC . . . Slaughtered and
retail poultry,
n = 100/220
Rectal swabs
(commensal) and
extraintestinal, n = 14
Phylogenetic group and virulence
genotype, n = 931f
Antimicrobial resistant human isolates were statistically more
similar to poultry isolates than to susceptible human isolates
(P < .001)
Dendrogram, n = 243f Antimicrobial resistant human isolates were more likely to cluster
with poultry isolates than with susceptible human isolates
(P < .001)
Abbreviations: AFLP, amplified fragment-length polymorphisms; CC, clonal complex; ESBL, extended spectrum β-lactamase; ESCR-EC, expanded-spectrum cephalosporin-resistant Escherichia coli; FPA, food-
producing animal; MLST, multilocus sequence typing; PFGE, pulsed-field gel electrophoresis; ST, sequence type.
a In some studies, multiple isolates were taken per sample, so the number of isolates may not reflect the number of positive samples.
b Multifactorial discriminant function analysis based on phylogenetic group, ESBL genotype, plasmid replicon type, and virulence genes (Wilks λ = 0.08).
c Selected O25b: H4 ST131 blaCTX-M-9 IbeA strains from 6 previous studies.
d Chicken (n = 2) and turkey (n = 1), selected from a combined pool of 1494 poultry and 408 turkey isolates collected between 1993 and 2009.
e Fifteen non-IbeA blaCTX-M-non-9–positive strains were also compared and found not to be similar.
f Based on phylogenetic group and virulence genotype of isolates. Non-ESCR isolates were included in analysis, and no subgroup analysis on ESCR isolates was performed.
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Table 2. Molecular Evidence Supporting Mobile Genetic Element–Mediated Transmission
Location,
Sampling Dates
Nature of Sample
Selection
Source and No. of ESCR Escherichia coli
Isolates
Major ESCR
Mechanism
Methods Used to
Exclude Whole
Bacterium
Transmission
Comparison of MGEs Across Sources
Animal Meat Human Methods Results
United Kingdom,
2006–2010
[30]
Selected blaCTX-M-14
isolates only
Cattle, n = 9
Poultry, n = 9
. . . Clinical, n = 7 blaCTX-M-14 PFGE and
virulence
genotype
PBRT, genetic
environment (of
ESBL) and ISEcp1,
nikB sequence and
RFLP with PstI
4 human isolates carried blaCTX-M-
14 on IncK, pCT-like plasmid,
highly related to plasmids from 9
cattle and 8 poultry isolates
Sweden, 2010
[25]
Selected blaCMY-2
isolates only
Broilers,
n = 22
. . . Clinical, n = 72
Healthy, n = 6
blaCMY-2 PFGE and MLST PBRT 19 human clinical isolates carried
CMY-2 on IncK, which was also
the case in 21/22 FPA isolates
France, 2007–
2009 [55]
Any ESCR-EC from
FPA but no human
isolates
Cattle, n = 9 . . . Clinical, reported
in UK, 2003 and
Italy, 2006 [65–
67]
blaCTX-M-15 No human isolates
for direct
comparison
PBRT, molecular size,
pMLST, and RFLP
with EcoRI
3 cattle isolates carried blaCTX-M-15
on IncFII plasmids similar to
those previously reported in
human E. coli infections [65–67]
Spain,
2006–2007
[27]
Highly selected, all
blaCTX-M-15, ST410,
and retrospective
. . . Turkey,
n = 2
Clinical, n = 5 blaCTX-M-15 PFGE
a PBRT, molecular size,
genetic environment
(of ESBL) including
ISEcp1. HpaI plasmid
digestion
All 7 isolates carried blaCTX-M-15 on
IncF1B plasmids of similar size,
with IS26 located 64 bp
upstream of ISEcp1. Digestion
profiles differ
Portugal,
2006–2007
[56]
Any ESCR-EC from
animals but no
human isolates
Pigs, n = 22 . . . Clinical, reported
in Portugal,
2003 [68]
blaTEM-52 No human isolates
for direct
comparison
PBRT, plasmid MLST,
and RFLP
8 pig isolates carried blaTEM-52c on
90kB IncI1 plasmid identified as
ST3. Previously identified in
human clinical isolates in
Portugal
Belgium,
2001–2007
[29]
Highly selected, all
plasmids
previously
analyzed
Poultry, n = 4
Pigs, n = 2
Non-EC,
n = 5b
. . . Nonclinical
(fecal), n = 3
blaTEM-52
blaCTX-M-2
blaCTX-M-15
Performed but
method not
disclosed
Conjugative resistance
transfer, size, PBRT,
RFLP, southern blot
hybridization
1 human isolate carried blaTEM-52
on IncI1 plasmid with similar
size and RFLP profile as 4 FPA
isolates. 2 remaining human
isolates did not share the same
RFLP pattern
Internationalc,
1995–2006
[53]
Highly selected, only
blaTEM-52 isolates
over 10-y period
Poultry, n = 2
Non-EC,
n = 5d
Chicken,
n = 3
Beef, n = 1
Clinical, n = 9 blaTEM-52 None performed PBRT, plasmid size,
ESBL gene location
relative to Tn3
transposon, RFLP
with EcoRI
1 human isolate carried blaTEM-52
on IncX1A plasmid highly
related to 4 meat isolates and 4
FPA isolates (Salmonella)
Spain,
2006–2007
[26]
Any ESCR-EC . . . Mixed,
n = 55e
Urine and blood,
n = 80
blaSHV-12
blaCTX-M-9
blaCTX-M-1
PFGE Distribution of genes
mediating ESCR
between meat and
human isolates
78 human isolates carried blaSHV-
12, blaCTX-M-9 or blaCTX-M-1
genes, which were identified in
45, 6, and 4 FPA isolates,
respectively
USA, 2006–2007
[26]
Any ESCR-EC . . . Mixed,
n = 34f
Urine and blood,
n = 47
blaCMY-2 PFGE
g Distribution of genes
mediating ESCR
between meat and
human isolates
21 human isolates carried blaCMY-2
gene, which was identified in 34
FPA isolates
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Table 2 continued.
Location,
Sampling Dates
Nature of Sample
Selection
Source and No. of ESCR Escherichia coli
Isolates
Major ESCR
Mechanism
Methods Used to
Exclude Whole
Bacterium
Transmission
Comparison of MGEs Across Sources
Animal Meat Human Methods Results
Canada, 1999–
2006 [28, 46]
Retrospectively
selected human
blaCMY-2 isolates
Cattle, n = 26 . . . Clinical, n = 22
[69]
blaCMY-2 PFGE PBRT, RFLP with Bg1II 5 human clinical isolates carried
blaCMY-2 on IncA/C plasmids that
were >85% similar to those
from 14 cattle on RFLP. 1 was
>95% and 2were > 90% similar
USA, 1998–2000
[31]
Any ESCR-EC from
multiple sampling
sites
Cow or pig,
n = 59
Non-EC,
n = 4h
. . . Urine, n = 5
Blood, n = 1
blaCMY-2 PFGE of all 65
ESCR E. coli
isolatesi
RFLP with EcoRI,
BamHI and or PstI;
Southern blot with
blaCMY-2 probe
1 human isolate carried blaCMY-2
on a plasmid with highly similar
restriction and Southern blot
profiles to those from FPAs (E.
coli and Salmonella spp)
Hong Kong,
2002–2010
[54]
Retrospectively
collected blaCTX-M-
14 isolates
Pigs, n = 14
Chickens,
n = 16
Cattle, n = 8
Pets, n = 20
. . . Clinical (UTI),
n = 37
Commensal
(fecal), n = 65
blaCTX-M-14 None performed PBRT, size, RFLP,
blaCTX-M-14 genetic
environment, plasmid
sequencing
5 clinical and 4 commensal
isolates carried blaCTX-M-14 on
IncFII plasmids with matching
restriction profiles (pHK01) to at
least 1 FPA isolate from each
animal source
Taiwan, 2001–
2002 [32]
Any ESCR-EC from
multiple sampling
sites
Poultry stool,
n = 1
Pig stool,
n = 7
Ground
chicken,
n = 14
Ground
pork,
n = 1
UTI, n = 11 blaCMY-2 RAPD and
ribotyping with
EcoRI and
HindIII
Plasmid size, RFLP with
EcoRI, co-transferred
resistance
7 human isolates carried blaCMY-2
on a 70–110 kb plasmid that had
the same RFLP profile as 3
ground pork isolates. 2 of the
human isolates also had
identical pattern of co-
transferred resistance
Abbreviations: EC, E. coli; ESBL, extended-spectrum beta-lactamase; ESCR, expanded-spectrum cephalosporin resistant; FPA, food-producing animal; MGE, mobile genetic element; PBRT, PCR-based replicon typing;
PFGE, pulsed-field gel electrophoresis; pMLST, plasmid multilocus sequence typing; RAPD, randomly amplified polymorphic DNA; RFLP, restriction fragment-length polymorphism analysis; UTI, urinary tract infection.
a Identified 81.2% similarity between clinical (n = 3) and both meat isolates.
b Klebsiella pneumoniae (n = 1) and Salmonella spp (n = 4) isolates from healthy poultry feces.
c Isolates collected from Denmark, France, Netherlands, Belgium, Spain, Korea, and Canada.
d Salmonella spp from poultry.
e Poultry (n = 15), pork (n = 3), beef (n = 1).
f Exact number of isolates not mentioned, sourced from poultry (n = 31), pork (n = 2), and beef (n = 1) samples.
g One clonal blaCTX-M-1–producing isolate in chicken meat and human sources was identified by PFGE; however, this was in the context of no other blaCTX-M being identified in poultry and the single isolate being a perfect
match, so the authors reasoned that this may have been a contaminant.
h Salmonella spp from bovine (n = 3) and porcine (n = 1) sources.
i Eight FPA and 2 human isolates underwent plasmid analysis.
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Table 3. Molecular Evidence That Does Not Support Whole Bacterium Transmission
Location, Sampling
Dates
Nature of Sample
Selection
Source and Number of ESCREscherichia coli Isolates Whole Bacterium Comparison
Animal Meat Human Methods Results
Internationala,
1967–2009 [34]
Highly selected Source not
specified,
n = 45
Source not
specified,
n = 6
Source not specified,
n = 486
Source distribution of
PFGE pulsotypes
Of 170 pulsotypes, 65 contained multiple isolates, of which 5
contained isolates from FPA and humans. Pulsotypes
containing FPA isolates were negatively associated with
those containing human isolates in the UK
UK, 2008 [33] No human isolates . . . Chicken,
n = 141
None, cf UK study [70] ESBL genotype Meat isolates carry blaCTX-M-2/8 genes, which are rare in human
clinical isolates in the UK [70]
MLST None of the isolates were ST131
Hungary, 2006–
2007 [35]
Any ESCR-EC Poultry, n = 5
Pigs, n = 4
Calves, n = 7
Turkey, n = 1
. . . Clinical, n = 45 ESBL genotype Human isolates mostly carried blaCTX-M-15, whereas FPA
isolates carried blaCTX-M-1
Phylogenetic group Human isolates were mostly B2 or D groups, whereas FPA
isolates were mostly A or B1 groups
Serotype 2/17 FPA isolates were typeable (O168, O8), whereas human
isolates were predominantly O25b-ST131
PFGE Human and FPA isolates did not share pulsotypes
Internationalb,
2005–2009 [40]
Any ESCR-EC Poultry,
n = 133
Cattle, n = 35
Turkey, n = 17
Pig, n = 16
. . . Clinical, n = 157c Virulence genotype
based on
microarray
At 40% similarity threshold, 15/42 (36%), 1/10 (10%), and 3/26
(12%) of the clusters containing human isolates also
contained animal isolates
MLST and virulence
genotype
1 human isolate from the Netherlands shared the MLST clonal
complex (ST23) and virulence cluster with a poultry isolate
from the same country; however, overall most human and
FPA isolates of the same ST type did not belong to the same
virulence cluster
UK, 2006–2009
[14]
Highly selected Poultry:
Healthy,
n = 26
Sick, n = 3
. . . Clinical, n = 10 ESBL genotype blaCTX-M-1, which was the main ESBL gene among FPA, is not
the predominant ESBL in UK hospitalized patients [71]
Virulence genotype 6/10 of virulence genes in human isolates were not identified in
FPA
Spain, 2005 [38] Sampled
environmental
waste
Poultry waste,
n = 9
. . . Urban waste, n = 1 Phylogenetic group Isolates from poultry waste belonged to groups A and B1,
whereas the isolate from urban waste belonged to group D
China, 2010–2013
[36]
Any ESCR-EC Pigs, n = 31 . . . Commensal, n = 46
Clinical, n = 36
ESBL genotype blaCTX-M-3 and blaCTX-M-15 found in human but not FPA sources
d
Phylogenetic group Group D prevalent in human isolates, whereas groups A and B1
prevalent in pigs
MLST ST10 group found in both human and FPA isolates
PFGE Isolates that belong to ST10 group were not clonal by PFGE
Japan, 2010 [37] No human isolates . . . Chicken,
n = 52e
None, compared with
published studies
[72, 73]
ESBL genotype Meat isolates carry blaCTX-M-2/8 genes, which are rare in human
clinical isolates in Japan [73]
Serotype Meat isolates that carry blaCTX-M-15 were not O25b, the main
serotype in human isolates [72]
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[41, 42] (Table 4). Resistance plasmids of the same replicon type
were identiﬁed in FPAs and humans; however, higher-resolu-
tion comparison by plasmid-MLST and PFGE found them to
be heterogeneous.
Observational Epidemiological Studies
Four observational epidemiological studies fulﬁlled our inclu-
sion criteria (Table 5). One ecological study and 2 case-control
studies supported the hypothesis of FPAs as a source of ESCR-
EC infections in humans [6, 43, 44]. One other case-control
study found that urinary tract infections caused by the ST131
strain of ESCR-EC was negatively associated with frequent con-
sumption of poultry, as compared to infections caused by non-
ST131 ESCR-EC [45].
DISCUSSION
Through the use of a systematic review, we present scientiﬁc
data related to the hypothesis that a proportion of human
ESCR-EC infections may originate from an FPA source. Specif-
ically, poultry in the Netherlands have been implicated as a
likely source of human infections. A variety of FPA and geo-
graphical regions have also been investigated, but the evidence
is mixed. Whole bacterium and MGE-mediated mechanisms of
transmission may both play a role.
At a population level, WBT is a phenomenon that is most
well characterized in the Netherlands, with 3 geographically
and temporally matched molecular epidemiological studies
being conducted there [15, 20, 21]. Unlike in other regions,
the evidence in the Netherlands is consistent across studies,
which used widespread and representative sampling methodol-
ogies and a range of well-validated molecular epidemiological
methods. These studies also consistently demonstrated an
unusually high proportion of human clinical extraintestinal in-
fections that could have resulted from a poultry source.
One recent study does not support these ﬁndings, but the
authors of that study highlight some limitations in their data,
when compared to previous work [40]. Perhaps the most signif-
icant of these is that genetic relatedness was evaluated by com-
paring similarity of virulence genotypes, which is a less stable
method than MLST and PFGE, because virulence genes are ac-
quired by horizontal transfer rather than spontaneous muta-
tions to the genetic backbone.
In the future, whole genome sequencing may be the most
methodologically sound and cost-effective way of conducting
molecular epidemiological analysis. In addition to providing
the highest possible discriminatory power, this method also re-
sults in a permanent data output that can be made easily acces-
sible for comparison between researchers.
Outside the Netherlands, 3 studies supported WBT, however,
all have limitations that precluded stronger conclusions beingTa
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drawn in these locations. Speciﬁcally, 2 Spanish studies found
only a very small number of related isolates [22, 23]. One of
these studies analyzed a highly selected population of bacteria
that had been collected over 17 years [23]. The North American
study relied on molecular techniques with limited discri-
minatory power, did not distinguish between ESCR-EC and
other forms of resistance, and lacked samples from human in-
fection [24].
A considerable body of work conducted outside of the Neth-
erlands has not demonstrated WBT. Seventeen publications,
mostly from Spain, North America, the United Kingdom, and
China, found evidence that did not support WBT using con-
temporary molecular epidemiological techniques [14, 25–28,
30–40, 46]. Supporting the validity of these negative ﬁndings,
8 of the studies identiﬁed MGE-mediated transmission instead
of WBT [25–32] (Table 2).
It is not clear whether the concentration of evidence support-
ing WBT in the Netherlands represents a truly geographically
deﬁned phenomenon or relates to the limited breadth and
methodology of research in other parts of the world. If a
geographical ﬁnding is real, the relatively high rates of antimi-
crobial use in animal husbandry in the Netherlands may be a
contributing factor [15]. Other potential factors, including dif-
ferences in farming practice, the food production and supply
chain, and human population dynamics, may warrant further
investigation.
One area of concordance among the molecular epidemiolog-
ical evidence of WBT is the identiﬁcation of poultry as the most
likely FPA source of ESCR-EC in humans. In several studies, re-
tail meat samples from beef, pork, and other FPAs either did not
harbor ESCR-EC [21, 37], or harbored strains clonally unrelated
to human infections (Tables 2 and 3). Certain multilocus
sequence types (ST10, ST155, and ST177), which have been
found in poultry and poultry products, appear to be most
frequently associated with a zoonotic risk [15, 20, 21]. Con-
versely, ST131, a common cause of human ESCR-EC infec-
tions, seems less likely to originate from poultry or other FPA
sources [34].
This apparent host speciﬁcity to poultry, and identiﬁcation of
ST10 as a high-risk strain, is consistent with existing studies
investigating zoonotic transmission of non-ESCR-EC [47–50].
It is also consistent with all 4 observational epidemiological
studies (Table 5), which collectively suggest that poultry is the
primary FPA host and that non-ST131 ESCR-EC strains may be
more likely to mediate this zoonotic potential [6, 43–45]. The
consistent identiﬁcation of poultry as a source, rather than
other FPAs, further supports the hypothesis of transmission.
Genomic data offer some explanation for this ﬁnding. Studies
have demonstrated that human extraintestinal pathogenic
E. coli and avian pathogenic E. coli share numerous virulence
factors [51, 52]. Therefore, resistant strains that are able to infectTa
bl
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Table 5. Observational Epidemiological Studies
Location,
Dates
Study
Design
Data From Food-Producing
Animals Data From Human Isolates Data for Comparison Method of Association and Results
Europea,
2005–2008
[6]
Ecological Prevalence of AMR among
Escherichia coli from
poultry, pigs, and cattle,
using surveillance datab
Prevalence of AMR in human
bloodstream E. coli infections,
using surveillance datac
Correlation of ESCR between FPAs
and human sources in 11 European
countries
Statistical correlation between poultry and human
ESCR across 11 European countries. r= 0.76
(P< .05, Spearman correlation coefficient)
Germany,
2011–2012
[43]
Case-
control
None Cases = hospitalized patients
colonized with CA-ESCR E. coli
Controls = patients colonized with
CA non-ESCR E. coli
Verbal questionnaire including dietary
habits in the past 12 mo;
multivariate analysis
Frequently eating pork (≥3 meals per week) was
independently associated with ESCR E. coli
colonization (OR = 3.5; 95% CI, 1.8–6.6).
Frequent consumption of poultry, beef, veal, and
fish were not associated
USA, 2003–
2004 [44]
Case-
control
None Cases =women with antimicrobial-
resistant E. coli UTI
Controls =women with fully
susceptible E. coli UTI
Verbal questionnaire including dietary
habits in the past 6 mo prior to UTI;
adjusted OR
Women with UTI caused by ampicillin or
cephalosporin-resistant E. coli reported more
frequent consumption of pork (adjusted
OR= 4.0; 95% CI, 1–15.5)
Women with multidrug-resistant E. coli UTI more
likely to report chicken exposure (adjusted
OR= 3.7; 95% CI, 1.1–12.4)
Paris, 2008–
2009 [45]
Case-
control
None Cases = inpatients with clinical
sample positive for blaCTX-M
positive ST131 E. colid
Controls = inpatients with clinical
sample positive for blaCTX-M
positive non-ST131 E. colid
Evaluated consumption of poultry,
beef, and raw meat; exposure to
livestock using unreported
method; multivariate analysis
Regular consumption of poultry products was
negatively associated with ST131 ESCR E. coli
infections (OR = 0.2; 95% CI, .1–.6); regular
consumption of beef, consumption of raw meat,
and exposure to livestock were not statistically
associated
Abbreviations: AMR, antimicrobial resistant; CA, community acquired (identified <72 hours after admission); CI, confidence interval; ESCR, expanded-spectrum cephalosporin resistant; FPA, food-producing animal; OR,
odds ratio; UTI, urinary tract infection.
a Eleven European countries: Austria, Denmark, Finland, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, and Switzerland.
b The Data from Animals originates from European Food Safety Authority.
c The Data from Humans originates from European Antimicrobial Resistance Surveillance.
d Consecutive inpatients across 10 hospitals in France with clinical E. coli sample positive for blaCTX-M.
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avian sources are also more likely to possess the cellular ma-
chinery required to infect humans.
The dynamics of MGE-mediated transmission of ESCR, be-
tween FPAs and humans, appear quite different to that of WBT.
Studies that support MGE-mediated transmission are charac-
terized by an extraordinary degree of diversity. Positive ﬁndings
originate from many regions, collectively encompassing all
major forms of livestock, across different species of Enterobac-
teriaceae with different ESCR resistance genes, plasmid types,
and MGEs [27–32, 46, 53–57].
Data also suggest some differences between ESCR gene clas-
ses. MGE-mediated transmission of ESBL genes may be primar-
ily mediated by whole plasmids [27, 29, 30, 53–55, 58], whereas
blaCMY-2 may move within a smaller MGE owing to its close re-
lationship with ISEcp1 [31], as described previously [10, 59].
The wide range of host Enterobacteriaceae and host FPA ob-
served in this form of transmission reﬂect a more ﬂexible and
ubiquitous phenomenon, where transmission of resistance can
occur independently of host bacterium speciﬁcity. There are,
however, some limitations with the studies that support MGE-
mediated transmission. Only a relatively small number of isolates
underwent comprehensive plasmid sequence analysis, perhaps
owing to high labor-intensity of this work. Most studies are
based on lower-resolution measures of plasmid similarity, such
as plasmid replicon types. Two recent European studies have
demonstrated a poor correlation between plasmid replicon typing
and higher-resolution techniques [41, 42]. However, the interpre-
tation of these 2 studies is unclear, because only a small number
of isolates underwent high-resolution comparison. Thus, the lack
of support may reﬂect an insufﬁcient sample size rather than a
true absence of relatedness.
The strengths of our systematic review include a comprehen-
sive search strategy, a structured approach to selecting articles,
and integration of data from multiple ﬁelds, including molecu-
lar and observational epidemiology.
Our review has a number of limitations. First, many molec-
ular epidemiology studies included in the review used inherent-
ly biased sampling methodologies, and only analyzed a small
number of isolates. Selection bias, and the associated heteroge-
neity of sampling methodologies, limits the conclusions that
can be drawn regarding the extent of the problem. Only 1
study was able to provide meaningful quantitative assessment
of the burden of FPA-associated ESCR-EC within a population
[15]. On the other hand, underpowered studies that did not ﬁnd
evidence of transmission can be difﬁcult to interpret, because
the absence of evidence may be due to an insufﬁcient sample
size rather than a true absence of relatedness.
Second, molecular epidemiological techniques have inherent
limitations, with considerable variability in the discriminatory
power afforded by the technique utilized [60]. Underlying this
limitation is the fact that genetic relatedness exists on a
spectrum. Dichotomous conclusions about “transmission” be-
tween 2 sources frequently require an element of subjective
judgment. The emerging use of whole-genome sequencing in
molecular epidemiology of Enterobacteriacae has already con-
ﬁrmed the inherent limitations of older techniques [61, 62],
and will certainly shape future research on this topic. Further-
more, genetic similarity also does not necessarily prove the or-
igin of transmission. For example, an external source that
contaminates FPAs and humans would also result in genetic
similarity. The potential for transmission mechanisms external
to the food chain deserves further research.
Research bias and publication bias may have inﬂuenced our
results. Most research effort has focused on a limited number of
geographical areas, almost all within the developed world. The
impact of publication bias is harder to ascertain, but likely pre-
sent. We identiﬁed a considerable number of negative studies in
this area, although approximately half of these results were pre-
sented in publications with other positive ﬁndings.
Owing to the speciﬁcity of the research question, we have also
limited the review to evaluate human infections caused by ESCR-
EC. Extraintestinal and intestinal human infection with other
species of ESCR Enterobacteriaceae of zoonotic origin, such as
Salmonella species, also appears to be a problem [31, 46].
Similarly, we have investigated only unidirectional transmis-
sion from animal to humans. Transmission in both directions is
possible, and may be responsible for the original incursion of
resistance into animal species [63]. A recent study from the
Netherlands indicates that the dynamics of the secondary
spread of FPA-associated resistant strains within human com-
munities are complex, and will require further research [64].
In conclusion, there is evidence that a proportion of human
extraintestinal ESCR-EC infections originate from FPAs. Poul-
try appears to be a more likely source than other FPAs based on
current evidence. Transmission of whole ESCR-EC and mobile
ESCR genetic elements from poultry to humans probably oc-
curs, but the speciﬁc parameters surrounding this, including
the magnitude and geographical extent of the problem, remain
inadequately understood. A broader sampling methodology, in-
cluding environmental and human commensal samples, and
higher-resolution molecular comparisons are required. Such re-
search would also lend insight into the speciﬁc mechanisms in-
volved in transmission and potentially offer a means for public
health intervention.
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